scispace - formally typeset
M

Michael Spencer Chapman

Researcher at Wellcome Trust Sanger Institute

Publications -  21
Citations -  1242

Michael Spencer Chapman is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Biology & Haematopoiesis. The author has an hindex of 7, co-authored 15 publications receiving 176 citations. Previous affiliations of Michael Spencer Chapman include Cambridge University Hospitals NHS Foundation Trust & Imperial College Healthcare.

Papers
More filters
Journal ArticleDOI

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

Katherine A Twohig, +607 more
TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.
Journal ArticleDOI

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, +672 more
- 07 Jul 2022 - 
TL;DR: In this article , the authors demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273.529.
Journal ArticleDOI

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Paul Elliott, +592 more
- 02 Nov 2021 - 
TL;DR: In this article, the authors assessed RT-PCR swab-positivity in the REAL-time Assessment of Community Transmissibility (RACT) in many countries associated with the Delta variant.